Stock listing

Tradegate:YAG Atossa Therapeutics, Inc. Aktie

German listing (Tradegate) of Atossa Therapeutics, Inc. · home listing NASDAQ:ATOS

Follow Atossa Therapeutics, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:ATOS

$2.91 USD +0.26 (+9.8%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ATOS

Since Jul 6, 2026 +27.6% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
$2.51 – $2.95 USDOct 16, 2026
Volume
104,496 sharesOct 16, 2026
Market value
$29.04M USDAt the close on Oct 16, 2026 · price × 9.98M shares outstanding
Atossa Therapeutics, Inc. logo
Ticker
Tradegate:YAG
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Tradegate
Currency
EUR

What changed lately

Calls

Replays

  • Atossa Therapeutics (NASDAQ:ATOS) Q4 2024 Earnings Call

    Tue, Mar 25, 2025 · 8:30 AM ET

    Watch Transcript
  • Atossa Therapeutics (NASDAQ:ATOS) Q4 2023 Earnings Call

    Tue, Mar 26, 2024 · 9:00 AM ET

    Watch Transcript
  • Atossa Therapeutics (NASDAQ:ATOS) Q3 2023 Earnings Call

    Thu, Oct 26, 2023 · 9:00 AM ET

    Watch Transcript

Latest news

All Atossa Therapeutics, Inc. news

Decks

Atossa Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
33 in the last 12 months · 186 in all · newest Oct 19, 2026 · oldest 2019
Calls
4 calls with a replay · 4 with a transcript · latest Mar 25, 2025
Decks
9 decks · latest September 2026

Where Atossa Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:ATOS · Home listingNASDAQUnited StatesUSD
BMV:ATOSBMVMexicoMXN
Tradegate:YAG · This pageTradegateGermanyEUR
gettex:YAGgettexGermanyEUR
LS Exchange:A2JJ99LS ExchangeGermanyEUR
BIVA:ATOSBIVAMexicoMXN
BOATS:ATOSBOATSUnited StatesUSD
Lang & Schwarz:A2JJ99Lang & SchwarzGermanyEUR
LS Exchange:A41ZVBLS ExchangeGermanyEUR
Dusseldorf:YAGDusseldorfGermanyUSD
Frankfurt:YAGFrankfurtGermanyEUR
Lang & Schwarz:A41ZVBLang & SchwarzGermanyEUR
Munich:YAGMunichGermanyEUR

Log in to ask 6ix AI your own questions about Atossa Therapeutics, Inc.